Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) — Net Asset Quality Index
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Net Asset Quality Index of 50.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.07 Billion minus total liabilities of CN¥1.03 Billion yields net assets of CN¥1.05 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 002923 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhuhai Rundu Pharmaceutical Co Ltd Class A Net Asset Quality Index Over Time (2011–2024)
This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 50.5%, representing net assets of CN¥1.05 Billion against total assets of CN¥2.07 Billion CNY. See Zhuhai Rundu Pharmaceutical Co Ltd Class short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Zhuhai Rundu Pharmaceutical Co Ltd Class market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 52.5% | CN¥1.15 Billion | CN¥2.19 Billion | CN¥1.04 Billion | ▼ -0.4 pp |
| 2023 | 52.9% | CN¥1.18 Billion | CN¥2.23 Billion | CN¥1.05 Billion | ▲ +0.6 pp |
| 2022 | 52.3% | CN¥1.20 Billion | CN¥2.29 Billion | CN¥1.09 Billion | ▼ -5.9 pp |
| 2021 | 58.2% | CN¥1.11 Billion | CN¥1.91 Billion | CN¥797.28 Million | ▼ -10.3 pp |
| 2020 | 68.6% | CN¥1.04 Billion | CN¥1.51 Billion | CN¥475.54 Million | ▼ -2.3 pp |
| 2019 | 70.9% | CN¥940.29 Million | CN¥1.33 Billion | CN¥386.39 Million | ▼ -5.7 pp |
| 2018 | 76.5% | CN¥871.29 Million | CN¥1.14 Billion | CN¥267.13 Million | ▲ +7.3 pp |
| 2017 | 69.2% | CN¥488.84 Million | CN¥706.00 Million | CN¥217.16 Million | ▲ +4.7 pp |
| 2016 | 64.6% | CN¥398.19 Million | CN¥616.60 Million | CN¥218.42 Million | ▲ +2.4 pp |
| 2015 | 62.2% | CN¥310.72 Million | CN¥499.72 Million | CN¥189.00 Million | ▼ -10.6 pp |
| 2014 | 72.8% | CN¥273.31 Million | CN¥375.41 Million | CN¥102.10 Million | ▲ +4.2 pp |
| 2013 | 68.6% | CN¥236.29 Million | CN¥344.54 Million | CN¥108.25 Million | ▲ +0.8 pp |
| 2012 | 67.8% | CN¥199.43 Million | CN¥294.06 Million | CN¥94.63 Million | ▼ -1.5 pp |
| 2011 | 69.3% | CN¥165.33 Million | CN¥238.62 Million | CN¥73.29 Million | — |